Bit.bio expands portfolio targeting neurological conditions
It's products will target neurological diseases such as epilepsy, schizophrenia, autism and Alzheimer’s.
App for monitoring Parkinson’s disease gets FDA clearance
Parky App monitors symptoms such as tremors and dyskinesia in real-time via the use of the Apple Watch.
‘SuperAgers’ study explores secret to longevity and ageing
Seeking DNA and health histories from 10,000 people, the enormous dataset is expected to assist researchers for decades.
Home care provider Cera reduces costs of healthcare this winter
Europe’s largest provider of digital-first home healthcare, Cera, is further [...]
Investment firm Kain Capital moves into hospice and palliative care sector
The acquisition of Hospice Corporation of America by Kain Capital's [...]
AI blood testing technology can detect 80% of liver cancers
A new artificial intelligence blood testing technology has been shown [...]
Study: Could Apple AirPods double up as hearing aids?
Researchers behind a new study in the US, say some [...]
New technology aims to detect early-stage Alzheimer’s
The dual-mode brain-sensing device can detect Alzheimer’s disease (AD) quickly and effectively.
BioArctic AB develops disease modifying treatment for Parkinson’s
The company plans to utilise its proprietary Brain Transporter technology
Study is first step towards blood-based screening tool for Alzheimer’s
Researchers are working on identifying immune deficits that are associated with the development of the disease.
